Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis.
Luttwak E, Robin ET, Drill E, Boardman A, Caron P, Epstein-Peterson Z, Falchi L, Ghione P, Hamlin PA, Horwitz SM, Intlekofer AM, Johnson W, Kumar A, Lue J, Noy A, Owens C, Palomba ML, Steiner R, Stuver R, Torka P, Vardhana S, Zelenetz AD, Salles G, Moskowitz CH, Moskowitz AJ.
Luttwak E, et al. Among authors: kumar a.
Leuk Lymphoma. 2025 Jul;66(7):1276-1283. doi: 10.1080/10428194.2025.2465553. Epub 2025 Mar 1.
Leuk Lymphoma. 2025.
PMID: 40598813